|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | +1.60% |
|
+2.94% | -1.31% |
| 10/06 | Organon wins US approval to widen use of arthritis biosimilar drug | RE |
| 10/06 | Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon | RE |
| Market Cap | 258B 324B 280B 242B 451B 30,846B 461B 3,069B 1,190B 14,939B 1,215B 1,189B 51,950B | P/E ratio 2026 * |
17.4x | P/E ratio 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise value | 269B 337B 291B 251B 469B 32,078B 480B 3,192B 1,238B 15,535B 1,264B 1,237B 54,024B | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 4.02x |
| Free-Float |
88.78% | Yield 2026 * |
3.1% | Yield 2027 * | 3.17% |
Last Transcript: Roche Holding AG
| 1 day | +1.60% | ||
| Current month | +0.50% | ||
| 3 months | -1.85% | ||
| 6 months | +1.89% | ||
| Current year | -1.31% |
| Current year | 315.6 |  | 374.9 |
| 1 year | 243.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.60% | +2.94% | - | - | 319B | |
| -0.73% | +5.34% | +40.78% | +154.77% | 1,021B | |
| +0.63% | +6.83% | +52.44% | +49.05% | 571B | |
| -0.21% | +3.60% | +18.71% | +62.79% | 398B | |
| -1.23% | +1.92% | +23.84% | +14.96% | 283B | |
| +0.56% | +4.86% | +22.00% | +32.02% | 272B | |
| -1.98% | -0.14% | +15.10% | +54.38% | 186B | |
| +5.05% | +4.16% | -45.54% | -48.13% | 185B | |
| -3.20% | -5.82% | +10.35% | +55.50% | 156B | |
| -0.39% | +1.03% | +5.35% | -34.31% | 146B | |
| Average | +0.01% | +1.62% | +15.89% | +37.89% | 357.5B | |
| Weighted average by Cap. | -0.04% | +3.51% | +27.51% | +71.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.58B 78.43B 67.88B 58.55B 109B 7,472B 112B 743B 288B 3,619B 294B 288B 12,584B | 65.13B 81.63B 70.65B 60.93B 114B 7,777B 116B 774B 300B 3,766B 306B 300B 13,097B |
| Net income | 15.16B 19B 16.44B 14.18B 26.46B 1,810B 27.05B 180B 69.83B 876B 71.3B 69.77B 3,048B | 16.22B 20.33B 17.59B 15.17B 28.32B 1,937B 28.95B 193B 74.74B 938B 76.31B 74.67B 3,262B |
| Net Debt | 10.31B 12.93B 11.19B 9.65B 18B 1,231B 18.41B 123B 47.52B 596B 48.52B 47.48B 2,074B | 3.44B 4.31B 3.73B 3.22B 6B 410B 6.14B 40.84B 15.84B 199B 16.17B 15.83B 691B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/06/26 | 323.90 CHF | +1.60% | 1,329,930 |
| 09/06/26 | 318.80 CHF | -1.21% | 1,844,589 |
| 08/06/26 | 322.70 CHF | -1.35% | 626,869 |
| 05/06/26 | 327.10 CHF | +0.77% | 1,148,657 |
| 04/06/26 | 324.60 CHF | +4.17% | 1,476,493 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition